About Dendrite
Dendrite is a Healthcare company based in Antwerp (Belgium) founded in 1986, and was acquired by Cegedim in March 2007. Its focus areas include HealthTech, Life Sciences Tech, Sales & Marketing and Life Sciences.
Company details
Dendrite International provides services and software for managing and analyzing sales efforts for the pharmaceutical and other life sciences industries. Solutions cover the pharmaceutical commercialization process and fit into five primary categories, including clinical development, brand marketing, customer management, sales effectiveness, and compliance management. Dendrites sales technology and applications enable sales forces to access product information and physician databases, assess competitors, and catalog client and prospect data. Support services include software implementation, technical and hardware support, and sales force support. It was listed in NASDAQ with the symbol DRTE and was later acquired by Cegedim post which it was closed for public trading.
- Headquarters Antwerp, Belgium
- Stage Acquired
- SectorsHealthcare
- Website dendrite.com
- Acquired by Cegedim (Mar 2007)
- Legal Name Dendrite
Funding Insights of Dendrite
- Total Rounds 1
- Last Round Unspecified — $3M
- First Round $3M
(Sep 1991)
- Investors Count 1
All 1 funding rounds of Dendrite with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 1991 | $3M | Unspecified | – | Edison Partners | – |
2 investors in total: 2 institutional.
Investors in Dendrite
Dendrite has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Cegedim and Edison Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of a growth equity firm for adaptive and personalized plans | edisonpartners.com | Princeton, United States | ||
Digital data flow management services | 1969 | cegedim.com |
Investor details for Dendrite
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Dendrite
3 dated milestones of Dendrite across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Dendrite is founded.
- Funding First funding round of $3.0M.
- Exit Acquired by Cegedim.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dendrite
Dendrite was founded in 1986 and raised its 1st funding round 5 years after it was founded.
Dendrite is headquartered in Antwerp, Belgium.
Annual revenue of Dendrite is $40.79K as on Dec 31, 2021.
Dendrite International provides services and software for managing and analyzing sales efforts for the pharmaceutical and other life sciences industries. Solutions cover the pharmaceutical commercialization process and fit into five primary categories, including clinical development, brand marketing, customer management, sales effectiveness, and compliance management. Dendrites sales technology and applications enable sales forces to access product information and physician databases, assess competitors, and catalog client and prospect data. Support services include software implementation, technical and hardware support, and sales force support. It was listed in NASDAQ with the symbol DRTE and was later acquired by Cegedim post which it was closed for public trading.
Dendrite has 2 investors. Key investors include Cegedim, and Edison Partners.
Dendrite operates through Dendrite.
Yes. Dendrite was acquired by Cegedim in March 2007.